Frontlight ResearchEarly access
Trial site
Diabet2 s.r.o.
- 2running trials
- 5closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes6 trials
- Obesity2 trials
- Coronary artery disease1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Status
- Completed5 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Novo Nordisk A/S3 trials
- Amgen1 trial
Running trials
Not yet recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026